Drug Development

The blueprint will enable the development of tailor-made drugs to treat epilepsy or cardiovascular diseases

Research results could one day lead to advanced screening methods to discern who is at greatest risk of developing disease

Robust workflow solution enables rapid, high throughput protein affinity purifications

Live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic

KIT scientists develop process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip

The journey from lead discovery to final approval can be long and challenging